Literature DB >> 1011412

Chronic mountain sickness.

C C Monge, J Whittembury.   

Abstract

Chronic mountain sickness was first described in the Peruvian Andes. It consists of an excesive polycythemia for the altitude of residence. Its main symptoms are of cerebral congestion and occasionally of right heart insufficiency. The authors postulate that it is caused by a decay of the ventilatory rate with age with the corresponding increase in hematocrit.

Entities:  

Mesh：

Year:  1976        PMID： 1011412

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN： 0021-7263


  15 in total

Review 1.  Genetic determinants of Tibetan high-altitude adaptation.

Authors:  Tatum S Simonson; Donald A McClain; Lynn B Jorde; Josef T Prchal
Journal:  Hum Genet       Date:  2011-11-09       Impact factor: 4.132

2.  Whole-genome sequencing uncovers the genetic basis of chronic mountain sickness in Andean highlanders.

Authors:  Dan Zhou; Nitin Udpa; Roy Ronen; Tsering Stobdan; Junbin Liang; Otto Appenzeller; Huiwen W Zhao; Yi Yin; Yuanping Du; Lixia Guo; Rui Cao; Yu Wang; Xin Jin; Chen Huang; Wenlong Jia; Dandan Cao; Guangwu Guo; Jorge L Gamboa; Francisco Villafuerte; David Callacondo; Jin Xue; Siqi Liu; Kelly A Frazer; Yingrui Li; Vineet Bafna; Gabriel G Haddad
Journal:  Am J Hum Genet       Date:  2013-08-15       Impact factor: 11.025

Review 3.  The genetic basis of chronic mountain sickness.

Authors:  Roy Ronen; Dan Zhou; Vineet Bafna; Gabriel G Haddad
Journal:  Physiology (Bethesda)       Date:  2014-11

4.  Low haemoglobin concentration in Tibetan males is associated with greater high-altitude exercise capacity.

Authors:  T S Simonson; G Wei; H E Wagner; T Wuren; G Qin; M Yan; P D Wagner; R L Ge
Journal:  J Physiol       Date:  2015-06-25       Impact factor: 5.182

Review 5.  High-altitude adaptation in humans: from genomics to integrative physiology.

Authors:  Priti Azad; Tsering Stobdan; Dan Zhou; Iain Hartley; Ali Akbari; Vineet Bafna; Gabriel G Haddad
Journal:  J Mol Med (Berl)       Date:  2017-09-26       Impact factor: 4.599

6.  ARID1B, a molecular suppressor of erythropoiesis, is essential for the prevention of Monge's disease.

Authors:  Andrew B Caldwell; Srinivasan Ramachandran; Priti Azad; Nathanael J Spann; Ali Akbari; Francisco C Villafuerte; Daniela Bermudez; Helen Zhao; Orit Poulsen; Dan Zhou; Vineet Bafna; Shankar Subramaniam; Gabriel G Haddad
Journal:  Exp Mol Med       Date:  2022-06-07       Impact factor: 12.153

7.  Contribution of polycythaemia to pulmonary hypertension in simulated high altitude in rats.

Authors:  G R Barer; D Bee; R A Wach
Journal:  J Physiol       Date:  1983-03       Impact factor: 5.182

8.  Protective effects of traditional Tibetan medicine Zuo-Mu-A Decoction () on the blood parameters and myocardium of high altitude polycythemia model rats.

Authors:  Meng-Qian Lu; Nyima Tsring; Tian-Yuan Yu; Jian-Cong Wu; Steven Wong; Guo-Yong Chen; Pasang Dekyi; Fan Pan; Si-Tong Xian; Dorje Rinchen; Ying-Qiu Mao; Lin-Feng Zhang; Bin-Bin Yao
Journal:  Chin J Integr Med       Date:  2016-05-04       Impact factor: 1.978

9.  VEGFA SNPs and transcriptional factor binding sites associated with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau.

Authors:  Norman E Buroker; Xue-Han Ning; Zhao-Nian Zhou; Kui Li; Wei-Jun Cen; Xiu-Feng Wu; Wei-Zhong Zhu; C Ronald Scott; Shi-Han Chen
Journal:  J Physiol Sci       Date:  2013-04-04       Impact factor: 2.781

10.  Cardiometabolic correlates of sleep disordered breathing in Andean highlanders.

Authors:  Luu V Pham; Catherine H Miele; Noah G Schwartz; Rafael S Arias; Adi Rattner; Robert H Gilman; J Jaime Miranda; Vsevolod Y Polotsky; William Checkley; Alan R Schwartz
Journal:  Eur Respir J       Date:  2017-06-15       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.